BioCentury's websites will be down for upgrades starting at 9 p.m. PDT on Monday, August 26. We expect the downtime to last no more than 6 hours, and we apologize for any inconvenience.

12:00 AM
 | 
Jan 17, 2011
 |  BC Week In Review  |  Clinical News  |  Clinical Status

LEE011: Phase I started

Novartis began an open-label, dose-escalation, international Phase I trial to evaluate daily oral LEE011 in 60 patients. The trial start triggered an undisclosed milestone payment to Astex from Novartis under a...

Read the full 131 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >